Drug Metabolism & Pharmacokinetics (DMPK) | Charles River Preclinical Services

biotransformation 

Charles River offers a comprehensive and integrated service for the isolation, analysis, and identification of metabolites in biological matrices in support of drug safety studies. This service can be provided as part of a full ADME package or as a stand-alone study.

Capabilities

  • Normal phase, reverse phase, chiral, ion exchange HPLC (with UV, fluorescence, and radiodetection), and thin-layer chromatography with phosphor imaging for metabolite profiling and isolation
  • Q-Trap MS for MSn
  • QSTAR and Micromass QTOF MS for definitive metabolite identification by accurate mass measurement, plus MetaboLynx™ Application Manager to aid data interpretation
  • Synthetic chemistry for synthesis of metabolites, reference standards and internal standards, iodine labeling of proteins, and re-purification of radiochemicals
  • Data interpretation by experienced biotransformation scientists in conjunction with client
  • Advice on radiosynthesis
  • Access to NMR – 1D, 1H, 13C, 19F, 31P (up to 800MHz)
  • Access to NMR – 2D COSY, NOESY, 13C-1H correlation
Discover the full range of Charles River Products and Services

For more information please call:

1.877.CRIVER.1 (1.877.274.8371)
askcharlesriver@crl.com

view all

News & Events

view all
Mar 09 - New Endotoxin Data Management Soft...
Mar 08 - Rodent Intravenous Infusion Capabi...
Apr 07-Apr 10 - La Grande Motte, France - Perspectives in Percutaneous Penetration: 12t...
Mar 22-Mar 23 - San Francisco, CA - 2010 PMF Bacterial Endotoxin Summit
May 05-May 05 - Tempe, AZ - Rodent Colony and Disease Management Considerations – A Sem...
view all
Veterinary Pathologist II Reno, NV
Corporate Sr. VP, Corporate Development 

Charles River Laboratories, Inc.